InsiderClue
Insiders · Profile

LINK WILLIAM J PHD

Director at Tarsus Pharmaceuticals · Director at RxSight · Director at GLAUKOS · and 1 more. Filing since 31 May 2016. CIK 0001228684

TARS Tarsus Pharmaceuticals, Inc. Director · 7 trades RXST RxSight, Inc. Director · 2 trades GKOS GLAUKOS Corp Director · 5 trades EW Edwards Lifesciences Director · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TARS Tarsus Pharmaceuticals, Inc.
15 Sep 2026
Director
Sold on a plan
12,500
$979.74K
11.7%
TARS Tarsus Pharmaceuticals, Inc.
15 Jun 2026
Director
Sold on a plan
12,500
$776.50K
10.5%
TARS Tarsus Pharmaceuticals, Inc.
16 Mar 2026
Director
Sold on a plan
12,500
$859.82K
9.7%
TARS Tarsus Pharmaceuticals, Inc.
15 Dec 2025
Director
Sold on a plan
12,500
$1.02M
8.8%
TARS Tarsus Pharmaceuticals, Inc.
15 Dec 2025
Director
Sold on a plan
10,446
$846.86K
100%
TARS Tarsus Pharmaceuticals, Inc.
8 Sep 2025
Director
Sold at will
27,116
$1.55M
15.9%
TARS Tarsus Pharmaceuticals, Inc.
12 Aug 2024
Director
Sold at will
35,000
$912.96K
100%
RXST RxSight, Inc.
1 Feb 2024
Director
Sold at will
28,250
$1.40M
53.8%
RXST RxSight, Inc.
3 Aug 2021
Director
Bought
31,250
$500.00K
533%
GKOS GLAUKOS Corp
1 Dec 2020
Director
Sold, plan not stated
50,000
$3.40M
76.4%
EW Edwards Lifesciences
21 Aug 2019
Director
Sold, plan not stated
6,914
$1.53M
41.1%
EW Edwards Lifesciences
21 Aug 2019
Director
Sold, plan not stated
1,650
$366.33K
25.9%
EW Edwards Lifesciences
20 Aug 2019
Director
Sold, plan not stated
1,650
$367.92K
8.9%
EW Edwards Lifesciences
19 Nov 2018
Director
Sold, plan not stated
13,578
$2.04M
69.2%
GKOS GLAUKOS Corp
15 Nov 2018
Director
Sold, plan not stated
27,025
$1.55M
40.0%
GKOS GLAUKOS Corp
13 Nov 2018
Director
Sold, plan not stated
14,475
$839.69K
16.0%
EW Edwards Lifesciences
9 Feb 2018
Director
Sold, plan not stated
12,000
$1.47M
42.9%
EW Edwards Lifesciences
29 Nov 2016
Director
Sold, plan not stated
15,000
$1.26M
34.9%
GKOS GLAUKOS Corp
17 Nov 2016
Director
Sold, plan not stated
30,000
$1.01M
25.5%
GKOS GLAUKOS Corp
31 May 2016
Director
Sold, plan not stated
34,058
$816.71K
39.9%
20 decisions on file.